Related Experiment Video
Updated: Jul 19, 2026

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia
Abstract:
Tamsulosin, a uroselective alpha(1A)-adrenergic-receptor antagonist, has been shown to improve lower urinary tract symptoms associated with benign prostatic hyperplasia. It has a better side effect profile than earlier alpha-adrenergic-receptor antagonists, which were initially developed as antihypertensive agents. Clinical trials of 1 year or longer with tamsulosin show high tolerability for the 0.4 mg dose and no significant interaction with other antihypertensive medications.
Related Concept Videos
Urodynamic Studies: Uroflowmetry
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Urologic Endoscopic Procedure: Cystoscopic Examination
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Urinary Tract Calculi III: Medical Management